Is this trial still ongoing? any more info to share? How to contact the research institution, sponsor, etc.? I'm G12D.

Thank you, boxhill, for your reply with valuable information.

This company says it developed a multi-targeted adjunctive therapy for cancer. It repurposes drugs that are approved in other indications to be used to target and slow down growth of cancer, to work together in a complementary way against cancer and enhance the activity of standard of care treatment...

F/65 – Dx Mar 18 Stage IIIA (T2N1M0), ascending colon and 33 nodes removed, spread to 2 nodes 6/18 – 9-18: 8 cycles of FOLFOX, severe neuropathy, low blood counts, Zarxio injections 11/18 – 4 lesions in rt liver lobe, 1/19: surgery resection, false alarm, lesions benign 4/19: 1 lesion (1.7 cm) left ...

F/65 – Dx Mar 18 Stage IIIA (T2N1M0), ascending colon and 33 nodes removed, spread to 2 nodes 6/18 – 9-18: 8 cycles of FOLFOX, severe neuropathy, low blood counts, Zarxio injections 11/18 – 4 lesions in rt liver lobe, 1/19: surgery resection, false alarm, lesions benign 4/19: 1 lesion (1.7 cm) left ...